P459: DISEASE MONITORING OF NPM1-MUTANT (MUT) ACUTE MYELOID LEUKEMIA (AML) USING MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENTS DURING ORAL AZACITIDINE (ORAL-AZA) TREATMENT (TX): A QUAZAR AML-001 SUBANALYSIS

Detalles Bibliográficos
Autores principales: Lopes De Menezes, Daniel, Roboz, Gail, Döhner, Hartmut, Wei, Andrew, Teresa Voso, Maria, Schuh, Andre, See, Wendy L., Ugidos, Manuel, Amzallag, Arnaud, Risueño, Alberto, H. Eng, Kevin, Nvs Suragani, Rajasekhar, Skikne, Barry, Beach, CL, Prebet, Thomas, Gandhi, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429241/
http://dx.doi.org/10.1097/01.HS9.0000968744.85748.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429241/
http://dx.doi.org/10.1097/01.HS9.0000968744.85748.62

Ejemplares similares